Reverse Transcriptase InhibitorsHIV Reverse TranscriptaseOrganophosphonatesAdenineAnti-HIV AgentsBenzoxazinesDrug Resistance, ViralHIV InfectionsHIV-1DeoxycytidineNevirapineDideoxynucleosidesLamivudineZidovudineHIV Protease InhibitorsDrug Resistance, Multiple, ViralDelavirdineDidanosineAntiretroviral Therapy, Highly ActiveOxazinesViral LoadRitonavirRNA-Directed DNA PolymeraseLopinavirStavudineNucleosidesAnti-Retroviral AgentsDrug Therapy, CombinationHIVCD4 Lymphocyte CountPyrimidinonesPyridazinesPyranocoumarinsAntiviral AgentsZalcitabineRNA, ViralDideoxynucleotidesPyrrolidinonesTreatment FailureMutationDrug CombinationsVirus ReplicationHIV ProteaseNelfinavirPyridinesRibonuclease HHIV Integrase InhibitorsHIV-Associated Lipodystrophy SyndromeTelomeraseTreatment OutcomeArea Under CurveReverse Transcriptase Polymerase Chain ReactionDrug InteractionsMolecular Sequence DataThymine NucleotidesAcidosis, LacticReverse Transcriptionpol Gene Products, Human Immunodeficiency VirusMutation, MissenseIntegrase InhibitorsDrug Administration SchedulePregnancy Complications, InfectiousGenotypeChemopreventionFuransHIV-2SaquinavirIndinavirAcquired Immunodeficiency SyndromeBase SequenceNitrilesDrug Resistance, MicrobialAnilidesTherapeutic EquivalencyCell LineBenzoxazolesSimian Acquired Immunodeficiency SyndromeOligopeptidesDose-Response Relationship, DrugAmino Acid SubstitutionInhibitory Concentration 50Protease InhibitorsPyridonesAdministration, OralAvian myeloblastosis virusLipodystrophyMedication AdherenceFoscarnetDNA, ViralErythrocebus patasDNA, MitochondrialProspective StudiesSulfur CompoundsTemplates, GeneticMicrobial Sensitivity TestsDrug DesignHepatitis B, ChronicPyrimidinesLeukocytes, MononuclearDeoxyadenosines